Bionano to Present at the 43rd Annual Cowen Healthcare Conference

Rhea-AI Summary

Bionano Genomics (Nasdaq: BNGO) announced its participation at the 43rd Annual Cowen Healthcare Conference. Erik Holmlin, Ph.D., the company's president and CEO, will present a corporate overview on March 6th, 2023, at 1:30 pm ET. The presentation will be available via a live webcast accessible on Bionano’s Investors website.

SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that company management will present at the 43rd Annual Cowen Healthcare Conference. Erik Holmlin, Ph.D., Bionano’s president and chief executive officer, is scheduled to present a corporate overview on Monday, March 6th, 2023 at 1:30 pm ET.

A live webcast of the presentation will be available to view on the Events page in the Investors section of Bionano’s website.  

CONTACTS

Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com 

Investor Relations:
Amy Conrad
Juniper Point
+1 (858) 366-3243
amy@juniper-point.com 

FAQ

When will Bionano Genomics present at the Cowen Healthcare Conference?

Bionano Genomics will present at the Cowen Healthcare Conference on March 6th, 2023, at 1:30 pm ET.

Who will represent Bionano Genomics at the conference?

Erik Holmlin, Ph.D., president and CEO of Bionano Genomics, will represent the company at the conference.

Where can I watch the presentation of Bionano Genomics?

The presentation can be viewed live via a webcast on the Events page in the Investors section of Bionano’s website.

What is the stock symbol for Bionano Genomics?

The stock symbol for Bionano Genomics is BNGO.

How can investors contact Bionano Genomics?

Investors can contact Bionano Genomics through Erik Holmlin at +1 (858) 888-7610 or via email at eholmlin@bionano.com.